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ABSTRACT 
Objectives 
Despite widespread availability of evidence-based guidelines to inform rational use of medicines, considerable 
unwarranted variation exists in prescribing.  A greater understanding of key determinants of contemporary 
prescribing in UK general practice could inform strategies to promote evidence-based prescribing.  This study 
explored (1) current influences on prescribing in general practice and (2) the possibility that general practice-
based pharmacists (PBPs) may contribute to greater engagement with evidence-based prescribing. 
Design  
Semi-structured, telephone interviews and a focus group were conducted, audio-recorded and transcribed 
verbatim.  Thematic analysis was undertaken. 
Participants 
(i) General practice prescribers: General Practitioners (GPs), PBPs, nurses. 
(ii) Key informants: Individuals within the National Health Service (NHS) with responsibility for influencing, 
monitoring and measuring general practice prescribing.  
Setting 
General practices and NHS organisations in England. 
Results  
Interviews with 17 prescribers (GPs (n=6), PBPs (n=6), nurses (n=5)) and six key informants, and one focus group 
with five key informants were undertaken between November 2018 and April 2019.  Determinants operating at 
individual, practice and societal levels impacted prescribing and guideline use.   Prescribers’ professional 
backgrounds e.g. nursing, pharmacy, patient populations and patient pressure were perceived as substantial 
influences, as well as media portrayal and public perceptions of medicines.   
Prescribers identified practice-level determinants of prescribing, including practice culture and shared beliefs.  
Key informants tended to emphasise higher-level influences, including NHS policies, availability of support and 
advice from secondary care and generic challenges associated with medicines use e.g. multi-morbidity. 
Participants expressed mixed views about the potential of PBPs to promote evidence-based prescribing in general 
practice. 
Conclusion 
Prescribing in UK general practice is influenced by multiple intersecting factors. Strategies to promote evidence-
based prescribing should target modifiable influences at practice and individual levels.  Customising strategies for 




General practice, guideline, evidence-based, pharmacist, qualitative, prescribing  
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ARTICLE SUMMARY 
Strengths and limitations of this study 
• This study explored a range of perspectives, including: 
o Medical and non-medical professionals prescribing in general practice (doctors, pharmacists and 
nurses) 
o Key informants working at various NHS levels who are influencing, monitoring and measuring 
general practice prescribing 
• The interview/focus group topic guides were developed flexibly to allow for exploration of additional 
topics  
• This study investigated the use of guidelines in general; research to explore the uptake of guidelines for 
specific medical conditions may reveal a different picture 
 
INTRODUCTION 
Medicines are the most common intervention used within the NHS 1.  They are vital to the prevention and 
treatment of illness, maintenance of health and management of chronic conditions.  NHS expenditure on 
medicines is eclipsed only by the staff budget 2.  Despite annual increases in spending to £17.4 billion (2016/17) 3, 
there is substantial evidence that medicines are not always used judiciously 4 5, with considerable unwarranted 
variation in practice 6 7 and sub-optimal patient outcomes 8 9.   
Although the National Institute for Health and Care Excellence (NICE) , established in 1999 to address problematic 
variation in NHS treatment availability and quality 10, issues a huge volume of prescribing advice and guidance to 
prescribers, inconsistent prescribing behaviour persists and is not fully explained by practice and patient variation 
11.  In accordance with major professional bodies, NICE endorses ‘Medicines Optimisation’ principles. 12  These 
explicitly promote prescribing based on individual patient experience, evidence and safety and highlight a balance 
between strict observance of guidelines and clinician judgement for individual patients.  
In contrast with most other countries, non-medical prescribing is a key feature of UK healthcare 13.  Whilst 
prescribing is embedded in undergraduate and postgraduate medical curricula, non-medical professionals 
undertake additional training to prescribe within their scope of competency.  Currently there are approximately 
48,000 nurse (independent or supplementary) prescribers 14 and 9,000 pharmacist independent prescribers 15.  
Many of these prescribers work in general practice.   
This study investigated influences (including the use of guidelines) on prescribing and the PBPs’ potential to 
optimise the use of evidence in prescribing in general practice.  The objectives were to explore: 
i. General practice prescribers’ perceptions of influences on their prescribing  
ii. Key informants’ perspectives about the ways in which prescribing in general practice is influenced, 
monitored and measured, including the use of NICE and other guidelines  
iii. The role and potential of PBPs to promote greater use of evidence in prescribing in general practice 
  
METHOD  
Study design  
The study adopted pragmatist principles 16, seeking to gain a practical understanding of participants’ experience 
of prescribing; data collection methods (interviews and focus group) suited to eliciting knowledge based on 
experience reflected this epistemological underpinning.  
To encourage participation, participants were offered either a telephone or face-to-face interview.  As a further 
boost to recruitment and to encourage an exchange of perspectives and experiences between key informants 17, 
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members of a Regional Medicines Optimisation Committee comprising five members were invited to attend a 
focus group as an adjunct to one of their half-yearly meetings. 
Recruitment 
Potential interviewees were initially identified through local, regional and national NHS networks and contacts 
and thereafter by snowball sampling 18.  Individual and practice characteristics reported to influence prescribing 
(e.g. experience, 19 and patient profile 20) were included in a sample matrix (Table 1).  Matrix elements were used 
to guide recruitment of (i) medical and non-medical prescribers in general practice and (ii) key informants working 
at local (one clinical commissioning group (CCG)), regional (across CCGs) and national NHS levels  in roles 
connected with general practice prescribing.  Recruitment ceased when all the matrix elements were addressed. 
Initial contact with potential participants was by email.  Sampling ceased when all matrix elements were filled. 
 
TABLE 1: Target recruitment matrix 





Role General Practitioner  
Practice-based pharmacist  
Nurse 







Years in current 
post 
≤ 2  
>2 
Employment Clinical Commissioning Group  
Practice 
NHS England 




Practice size (patient 
list) 
Small (< 5000 patients)  
Medium (5000 - ≤ 10000 
patients) 
Large (> 10000 patients) 
 




*Information from National General Practice Profiles 21 (lower numbers indicate more deprivation) 
 
Data collection 
Potential participants were sent an information sheet and asked to provide written informed consent prior to 
participation.  The topic guides (interview for prescribers and interview/focus group for key informants)  (see 
Supplementary Information) were informed by the literature and information from preliminary discussions with 
local and regional NHS contacts.  Questions focused on the participant’s role, perceived influences on prescribing, 
the experience of variation in prescribing and the role and potential of PBPs.  Guides were piloted with non-
participating pharmacists to check for relevance of questions and terminology and were refined during the study 
as new topics were identified 22.  Prior to the interview, participants were asked to provide brief details about 
themselves and the general practice or organisation in which they worked. 
All one-to-one interviews were conducted by telephone by one researcher (MC).  MC led the focus group, 
supported by a facilitator (NA, post-doctoral researcher) who made brief notes to support transcription of the 
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recorded discussion.  The interviews and focus group were digitally recorded, transcribed verbatim and 
identifying information removed (MC).  MC made short reflexive field notes. 
Data collection took place between November 2018 and April 2019.   
Data analysis 
Transcripts were coded using standard software QSR NVivo v11©.  Data were analysed interpretatively, focussing 
on participants’ perception and understanding of influences on prescribing 23, in two groups 1) from interviews 
with prescribers and 2) from interviews and focus group for key informants.  Topic guides included the same areas 
of investigation and allowed common experiences and perceptions between the groups to be identified.   Codes 
about the influences on prescribing and the PBP’s role were generated using reflexive thematic analysis 
techniques 24 by which participants’ experiences and perceptions were understood and categorised.  MC 
developed an initial framework of codes, which was applied by a mixed-methods researcher (AD, PhD student) to 
analyse and code a subset (n=6) of transcripts.  Both researchers subsequently discussed commonalities and 
differences in coding.  The framework was amended to reflect these discussions, and thereafter all transcripts 
were coded by MC using the refined coding framework.  Main themes and links between themes from all 
transcripts were discussed by MC and AD and agreed with the entire team.   
 
Both MC and AD had previously conducted qualitative research with general practices, but neither was a 
pharmacist or prescriber.  Two interviewees were known professionally to MC prior to participating. 
This report conforms to the Standards for Reporting Qualitative Research (SRQR) 25 and Consolidated Criteria for 
Reporting Qualitative Research (COREQ) 26 guidelines 
 
PATIENT AND PUBLIC INVOLVEMENT 
This study specifically focussed on the influences on prescribing; prescribers, key informants and patients were 
not involved in the design or conduct of the research.  
 
RESULTS  
Twenty-three interviews were completed with six GPs, 11 non-medical, independent prescribers (PBPs (n=6), 
nurses (n=5)) (Table 2) and six key informants.  One focus group was conducted with five key informants (Table 3) 
comprising representatives from a Regional Medicines Optimisation Committee (RMOC) whose members 
(decision-makers, healthcare professionals and patients) support and optimise local prescribing practice and 
reduce unwarranted variation regionally and nationally (in England).  Interviews lasted a mean of 41 minutes 
(range 24 – 53 minutes).  The focus group lasted 59 minutes.   
Most participating PBPs had direct experience of the Clinical Pharmacists in General Practice programme 27, a 
scheme funded by NHS England to support the introduction of pharmacists into general practice.  PBPs’ current 
roles varied, with most including responsibility for medicines reviews, repeat prescriptions and some audit work. 
The results are presented under theme headings in three sections: (i) Prescribers’ perspectives, (ii) Key 
informants’ perspectives, (iii) Comparison of prescriber and key informant perspectives.  The contributor of each 
quotation is denoted by a unique P (participant) number and role (GP, nurse, PBP, KI - key informant).  For key 
informants the NHS level at which s/he worked and I-interview or FG-focus group is indicated.   
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TABLE 2:  Prescriber and general practice characteristics 




















General Practitioners (GPs) 
P10 F Practice, England (West) 20  5000 – ≤ 10,000  ≤ 5  
P12 M Practice, England (South 
West) 
36  5000 – ≤ 10,000  > 5 
P13 F Practice, Scotland 
 
26  5000 – ≤ 10,000  > 5** 
P14 F Practice, England (South 
West) 
31  5000 – ≤ 10,000  > 5 
P16 F Practice, England (South 
West) 
26  > 10,000  > 5 
P18 F Practice, England (Midlands) 12  5000 – ≤ 10,000  ≤ 5 
Practice-based pharmacists (PBPs)  
P3 M Practice, England (South) > 10 > 5 > 10,000  > 5 














P11 M Practice, England (West) < 10 ≤ 5 > 10,000  > 5 
P22 M Practice, England (South) > 10 ≤ 5 > 10,000  ≤ 5 
P29 F Practice, England (East) < 10 ≤ 5 > 10,000  > 5 
P32 M Community pharmacy/ 
Practice, England (South) 
> 10 ≤ 5 5000 – ≤ 10,000  > 5 
Nurses  
P5 F Practice, Wales > 10 > 5 > 10,000  > 5** 
P1 M Practice, England (West) > 10 > 5 > 10,000  > 5 
P15 F Practice, England (West) > 10 > 5 > 10,000  > 5 
P19 F Practice, England (Midlands) > 10 > 5 > 10,000  ≤ 5 
P21 F Practice, England (South) > 10 ≤ 5 > 10,000  > 5 
*Information from National General Practice Profiles21 (lower numbers indicate more deprivation) 
**Derived from participant’s depiction of patient population 
P9 worked in four practices; P3 and P21 worked in the same practice 
All PBPs and nurses were independent prescribers  
 
TABLE 3: Key informant characteristics 
Participant 
no. 





Direct contact with 
general practices 
Interview or  
focus group 
 
P2 F >30 to ≤50 
years 
Local  ≤ 2 years Y Interview 
P4 F >50 years Regional >2 years Y Interview 
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P8 F >30 to ≤50 
years 
Local ≤ 2 years Y Interview 
P17 F >50 years National  >2 years N Interview 
P23 F >50 years Local & regional >2 years Y Interview 
P24 M >50 years Local & regional >2 years N Focus Group 
P25 F >30 to ≤50 
years 
Local & regional >2 years Y Focus Group 
P26 M >30 to ≤50 
years 
National & regional >2 years Y Focus Group 
P27 M >50 years Local & regional >2 years Y Focus Group 
P28 F >50 years National & regional >2 years Y Focus Group 
P31 M >50 years National & regional >2 years N Interview 
*  Local: working at individual Clinical Commissioning group level 
**  Regional: working across Clinical Commissioning Groups or regional body 
***  National: representative of/working on national body 
 
(i) PRESCRIBERS’ PERSPECTIVES 
Summary of prescribers’ perspectives (themes in bold text) 
Prescribers acknowledged that guidelines from NICE and other bodies were a predominant influence on their 
prescribing.  They also discussed the impact of their professional background and training, as well as experience 
and individual characteristics.  Patient characteristics, such as socio-economic features of local populations were 
frequently cited as an important determinant of prescribing, as was the organisational culture of the general 
practice.  Prescribers expressed a range of views about the current and potential roles of PBPs.   
National and local guidelines  
Prescribers from all professional groups reported that their prescribing was fundamentally influenced by 
information provided by NICE guidelines, their local Clinical Commissioning Group (CCG), condition-specific 
organisations and Royal Colleges: 
I suppose virtually everything that I see and talk about is influenced by NICE in the first instance, and the relevant 
NICE guidance, whatever it might be. P1, Nurse 
NICE guidance we’re heavily influenced by … number 1 is [name of CCG formulary] … number 2 is the NICE 
guidance and then I suppose number 3 is the British National Formulary, it’s every GP’s bible really. P14, GP 
Guidelines were often amplified by financial incentive schemes, such as the national Quality and Outcomes 
Framework (QOF) 28 and local initiatives e.g. from the CCG 29.  Prescribers commented on the impact of 
computerised decision-support tools, such as ScriptSwitch 30 and Optimise RX 31.  Some prescribers appreciated 
the real-time prompts from these systems:  
I personally find it a huge source of assurance and reassurance in my prescribing practice. P1, Nurse 
Others reported being overwhelmed by the information: 
There’s so much information sometimes like ‘do not prescribe this in pregnancy’ and it’s someone in their 50s 
… we are inclined to ignore that kind of information and then suddenly realise that … what it was flagging up 
was actually important. P13, GP 
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Professional background 
Many participants mentioned their own and colleagues’ professional background as influencing their prescribing.  
PBPs and nurses were frequently characterised, by themselves and others, as aware of their professional 
boundaries and ‘sphere of competence’ and therefore more likely to follow prescribing guidelines than their GP 
colleagues: 
I guess I’d make the distinction between GPs and independent prescribers … [the latter] … are a bit more 
cautious … you … have your area and you … won’t stray outside that.  So being educated before prescribing in 
new areas is much more important.  Whereas I think as far as the GPs go, they can prescribe anything and 
everything from day 1. P11, PBP 
Individual experience and qualities 
Individual prescribers’ accumulated experience and access to support, education and development opportunities 
were also considered to be important determinants of prescribing:   
So we might have a specialist in the field … recently we had a cardiologist consultant and he spoke about heart 
failure, so it was educational … it really helped weighing up the prescribing techniques that we use.  P22, PBP 
Individual qualities, such as confidence and ambition were also mentioned as influences on prescribing:  
I think you’re willing to learn, you’re willing to try new things and look at your own confidence and you’ve 
got to be really honest. P29, PBP  
Patient characteristics 
The socio-economic profile of the local patient population was identified by prescribers as an influence on their 
prescribing.  Several reported responding to the needs of deprived patient populations: 
Where I work, it’s quite a deprived area, life expectancy is generally a lot lower ... So our approach is very 
different, we really try to serve the needs of the local demographic...  if it was in a different setting we would 
be saying ‘go and buy this over the counter’ … that patient’s not really in a position where they would afford it. 
P22, PBP 
Some also mentioned the pressure of prescribing for an affluent and assertive population: 
[We] encourage [sic] people that things that are cheaper to buy over the counter would be better buying 
over the counter … But some of our patients are a bit resistant to the idea… a case of ‘why should we?  
We’ve paid tax, we should be getting these things.’ P13, GP 
Prescribers identified guidance from authoritative sources, such as NICE, as a tool for managing challenging 
demands from individual patients: 
NICE is what you turn to when the patient says ‘I want the drug that was in the Daily Mail last week’.  And you 
say ‘sorry I can’t prescribe that, it’s not been agreed by NICE yet.’ P12, GP   
Comments about managing patient demand highlighted differences between individual prescribers: 
I’m probably a bit too nice sometimes!  One of my colleagues is very good at just saying ‘no’.  For things like 
sleeping tablets.  I tend to do more negotiation, short supplies or weaning courses … rather than being a point 
blank ‘no’ person. P18, GP 
Organisational culture 
Prescribers discussed the culture within their general practice, including opportunities for informal learning from 
colleagues about new developments in guidelines and prescribing: 
We take group learning very seriously, we have clinical catch up at coffee, where if anyone has found any new 
exciting evidence or guidelines or examples of good practice we do tend to talk inter-professionally. P29, PBP  
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In practice, we don’t as a group kind of get together … as clinicians and feeding back information, events that 
have happened … significant events … we don’t have joint CPD [continuing professional development] events. 
P22, PBP 
Although prescribers often reported limited influence from the pharmaceutical industry (noted by some as being 
different from close relationships in the past), contact between practices and “drug reps” still continued in other 
forms: 
Every practice I’ve worked in has stopped seeing drug reps.  I think there is still advertising in Monthly Index of 
Medical Specialities and in things like the British Medical Journal … some of the fairly accessible GP free 
education has still got drug reps attending.  I don’t talk to them, but I’m always made to feel slightly bad for 
not talking to them because you’re always encouraged to. P10, GP 
Practice-based pharmacist (PBP) roles 
PBPs had differing employment models and patterns, with some individuals working as full members of the 
general practice team and others shared between several practices.  Experience varied considerably as did their 
access to training, support and development.   
Although other prescribers often mentioned the positive impact of PBPs’ complementary knowledge and skills, 
some GPs were cautious about PBPs’ potential impact on prescribing in general practice:  
Prescribing in the context of multi-morbidity is the sort of thing that experienced GPs offer … I think prescribing 
pharmacists could do really well, but when they’re into the more complex, multi-faceted, social, psychological 
issues and stuff that the generalist patients have, they would find it more difficult. P12, GP  
Participants expressed mixed views about PBPs’ potential to influence their colleagues’ prescribing practice, but 
many mentioned the importance of PBPs’ particular knowledge of medicines:  
They (PBPs) were invaluable as a source of information, in terms of kind of combinations of things and 
interactions P18, GP 
Some identified the types of tasks most appropriate for PBPs, including medicines review and reconciliation, 
repeat prescribing and patient education, but cautioned against PBPs duplicating tasks commonly undertaken by 
nurses.    
They’re certainly looking at the sheer burden of repeat prescribing and medicine management … that’s going 
to … be more pharmacist-driven to take some of the pressure off ourselves. P13, GP 
 
(ii) KEY INFORMANTS’ PERSPECTIVES 
Summary of key informants’ perspectives (themes in bold text) 
Key informants emphasised the fundamental influence of guidelines produced by NICE, CCGs and professional 
bodies on prescribing in general practice.  They highlighted the effect of strategic developments, the roll-out of 
NHS policies and medicines optimisation principles.  Key informants often suggested that a prescriber’s 
professional background and patient characteristics were important determinants of their prescribing and were 
concerned about variation in PBP roles and access to career support. 
National and local guidelines 
Key informants cited NICE guidelines as a key source of evidence used by prescribers in general practice, but also 
emphasised the guidance and associated formularies developed by local commissioning bodies, condition-specific 
organisations and Royal Colleges as equally important and invariably in tune with the national guidelines:   
If it’s on the formulary it’s accepted, you know, it is the formulary choice.  And actually now it’s the GPs who 
are pushing back, if a specialist says ‘why not use this?’ ‘yeah, but it’s not on the formulary.   
P27, KI, local/regional, focus group 
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NHS policies and organisation of services 
Several key informants were involved in developing NHS policies which they believed had a direct influence on 
prescribing: 
I think there is also a significant amount of influence resulting from national policy initiatives, so two recent 
examples that I could cite would be the items that shouldn’t be routinely prescribed in primary care and also 
conditions for which medicines shouldn’t be routinely prescribed.  P31, KI, regional/national, interview  
They also highlighted that the availability of external support (e.g. from secondary care) affects prescribing in 
general practice: 
Some areas have community geriatricians who help to support the prescribing with GPs and the pharmacists in 
the team, for people in care homes and those complex ones.  And in other places … that support isn’t there.  
P28, KI, regional/national, focus group 
Medicines Optimisation 
Key informants expressed concern about medicines and prescribing-related problems which they explicitly 
connected with an impetus to develop and embed medicines optimisation principles.   
Influences on prescribing in general practice included an increase in problematic polypharmacy, and the 
importance of patient-centred and safe prescribing: 
So it … will say first line this, add in that, add in this as a third drug … So you’ve only got to have two long term 
conditions …and you’ll be on six drugs before you know it.  P4, KI, regional, interview 
The fact that your liver might need some fancy drug might be of completely no interest to you if it means that 
you’re trekking off to the hospital all the time and you’re suffering from side effects and actually what you 
want to do is spend some time with your grandchildren.  P28, KI, regional/national, focus group 
If I want to get somebody to really think twice about the way they prescribe, then I always play the safety card 
… our prescribing incentive scheme for GPs is called the ‘quality prescribing and safety scheme’.  
P23, KI, local/regional, interview 
Professional differences 
Key informants attributed variation in prescribing to different professional backgrounds and training.  They mainly 
characterised nurses and PBPs as risk-averse and prescribing within strict limits, whereas GPs were considered to 
have the greatest ability and appetite for risk-taking and managing complex patients: 
 
I think nurses tend to be … a bit more protocol-driven and so tend to be quite focussed on an individual disease 
entity.  … Pharmacists I see have a slightly different risk appetite and they’re willing to juggle maybe two or 
three comorbidities and then, I would hope, what should come about is that GPs and doctors should be able to 
then multiple [sic] the more complex, multi comorbidities.  P27, KI, local/regional, focus group 
Patient characteristics 
Key informants reflected upon the influence of patients as individuals as well as populations (general and local). 
Public opinion and media messages about medicines were particularly mentioned: 
I mean just because it’s cancer doesn’t mean that the drugs always work, if only you can get your hands on 
them, which is how they’re portrayed in the media, isn’t it?  If only we could get this drug funded all would be 
well.  P28, KI, regional/national, focus group 
Key informants also recognised the importance of socio-economic factors in influencing prescribing in an area: 
Self-care is hugely on the agenda at the moment, encouraging patients to buy things over the counter, rather 
than getting them prescribed.  [Our] GPs are in a more deprived area and tend to feel that patients can’t 
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afford to buy those products and therefore they end up prescribing them.  P8, KI, local, interview 
Practice-based pharmacists (PBPs) 
Key informants recognised that PBPs had hugely variable roles, responsibilities and models of employment.  
Participants expressed mixed opinions about the best model; most favoured situating pharmacists within general 
practices.  Some believed that PBPs’ skills and time may be most effectively used within the emerging primary 
care networks, in which groups of practices are working together to provide a range of healthcare services for the 
local population. 
Participants reported variation between PBPs, particularly in terms of experience and skills, and expressed 
concern about differing levels of support and training available.  Some saw opportunities for career development 
as crucial to allowing PBPs to achieve their potential: 
We have this varied pattern of some people who come in more or less newly qualified to the role in a GP 
practice.  So the NHS England training is good, actually, but it only goes up to a certain point.  What 
happens to those people … where do they go next? (P28, KI, regional/national, focus group) 
 
(iii) COMPARISON:  Prescribers’ and key informants’ perspectives 
There was general agreement between prescribers and key informants about many of the influences on 
general practice prescribing (Figure 1, Comparison of prescriber and key informant perspectives).   
   
Both groups acknowledged that national and other prominent guidelines had considerable influence and 
emphasised the effects of prescribers’ professional backgrounds and experience.  Both groups identified 
individual patients, populations, the media and public opinion as having a substantial influence on prescribing. 
While prescribers identified influences on prescribing that may be shaped at a general practice level, such as 
attitudes towards shared learning, key informants highlighted the effect of NHS organisational policies and the 
availability of external support (e.g. from secondary care).  Key informants mentioned universal problems with 
medicines (e.g. polypharmacy) and the benefits of medicines optimisation principles for patient outcomes.  
Participants in both groups mentioned current wide variation in the role of the PBP.  Prescribers had mixed views 
about the potential for the PBP to address underlying workforce problems in general practice, and key informants 




This study identified a range of influences on prescribing in general practice by exploring the perspectives of 
prescribers and key informants.  Although the guidance provided by NICE and other bodies is frequently described 
as fundamental to informing prescribing decisions in general practice, this study highlighted a complex range of 
intersecting factors which impact on prescribers’ abilities or inclination to prescribe according to the available 
evidence.  The application of guidelines differs between professional groups, whose attitudes are shaped by their 
early and continuing training.  Patient characteristics (both individuals and populations) are also key influences.  
The role of the PBP varies between general practices, and this study has revealed some caution (especially 
amongst GPs) about the potential for increasing PBPs’ impact on general practice prescribing. 
Strengths and limitations 
Whilst prescribers were evenly drawn from the different professional groups identified at the study outset, most 
were from practices with medium to large list sizes (>5,000 patients) and with less deprivation.  All GPs recruited 
to the study had several years of experience.  Prescribers in smaller general practices, in areas of greater 
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deprivation, and with less experience may have provided additional insights into the factors influencing their 
prescribing.  Key informant participants were working at various levels within the NHS and encompassed a broad 
range of roles and perspectives.   
Flexible evolution of the interview topic guides allowed for exploration of additional issues raised by individual 
participants which had not been anticipated at the research design stage.  The focus group discussion with key 
informants was less researcher-led than the interviews and offered an opportunity for participants to interact 
with, probe and challenge each other.  A similar session with prescribers may have yielded alternative or 
additional observations, but this was not possible. 
This study explored the use of guidelines in general and the factors which intersect with them to influence general 
practice prescribing.  Research to explore the uptake of guidelines for specific medical conditions or to investigate 
prescribing in instances where evidence is unclear or existing guidelines are considered unhelpful, may provide 
different insights.  
Comparison with existing literature 
Previous research has highlighted differences between evidence, such as NICE guidelines, and prescribing in a 
range of healthcare settings 8 32.  This study identified several influences which general practice prescribers 
balance with the evidence-based approach promoted in guidelines when making  prescribing decisions, in 
particular their own professional background.  Sharing of responsibilities among prescribers from differing 
professional backgrounds may have resulted in variation in the use of guidelines, but some see non-medical 
prescribers as suited to promoting an evidence-based approach to prescribing 33.  Although all professional groups 
represented in this study acknowledged the importance of guidelines, nurses and pharmacists were perceived by 
themselves, GPs and key informants as more likely to prescribe in accordance with the available evidence than 
GPs.  This suggests that strategies to increase evidence-based prescribing should be tailored for professional 
groupings and reflect their different routes to acquiring prescribing skills.  Differences in the scope of prescribing 
routinely undertaken by medical and non-medical prescribers should also be considered. Participants explicitly 
mentioned the impact of local demographics on prescribing, which corresponds with previous research linking 
practice prescribing patterns with patient populations 34 35.   Taking account of local demographics and providing 
patient-centred care may impact the professional’s prescribing and perceptions about the appropriateness of 
guidelines.  This tension echoes previous research which identified competing ‘macro’ and ‘micro’ influences on 
prescribing 20 and the ‘explicit’ and ‘tacit’ types of knowledge which inform prescribing decisions 36. 
Previous research with GPs found that openness to sharing knowledge amongst general practice colleagues can 
shape and develop prescribing 37.  Some participants in this study worked in practices which encouraged diverse 
professionals to share new evidence and some did not.  Their reflections suggest that a collaborative culture may 
facilitate greater use of guidelines and reduce problematic variation in prescribing within teams.   
This study revealed more cautious attitudes, particularly among GPs, towards PBPs’ contribution to the general 
practice team than reported elsewhere 38 39.  PBPs who had been part of the NHS England scheme 27 40 were 
positive about the associated training, support and networking opportunities and these have previously been 
identified as important factors which optimise the complementary skills of prescribers from a pharmacy 
background; the ambition and aptitude of the individual are also influential 41. 
Implications for research and practice 
This study has demonstrated a range of complex and intersecting factors that affect prescribing in general 
practice and impact prescribers’ use of the evidence presented in guidelines.  These influences are not all 
amenable to modification and further analysis of the data to pinpoint flexible behaviours and determinants would 
be a useful next step.  Participants in our study expressed a range of views about the potential for PBPs to 
influence prescribing in general practice.  Capturing the views and experiences of a greater number of PBPs 
working in diverse practice contexts will provide a robust basis for developing strategies which involve PBPs in 
promoting the use of guidelines in general practice prescribing. These strategies should focus on the more flexible 
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influences on prescribing and take account of the different use of guidelines between prescribers from a range of 
professional backgrounds. 
Conclusion 
A multiplicity of influences impact prescribing in general practice and intersect with guidance from NICE and other 
bodies.  The effect of these influences is often experienced differently by medical prescribers who are less 
focused on guideline use than their non-medical colleagues.  Pharmacists and their general practice colleagues 
require a clearer definition of the PBP role to allow them to fulfil their potential to contribute to greater evidence-
based prescribing in general practice. 
 
Figure 1, Comparison of prescriber and key informant perspectives   
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